Test Details
Methodology
See individual tests.
Result Turnaround Time
5 - 10 days
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
Test Includes
Activated partial thromboplastin time; anticardiolipin antibody IgA, IgG, and IgM; antithrombin activity; β2-glycoprotein I, IgA, IgG, and IgM; dilute Russell's viper venom time (dRVVT) confirm seconds; dilute Russell's viper venom time (dRVVT) ratio; dilute Russell's viper venom time (dRVVT) screen seconds; factor II gene mutation; factor V Leiden; hexagonal phospholipid neutralization; homocysteine; lupus anticoagulant interpretation; protein C activity (chromogenic); protein S antigen, free
Use
For the investigation of common acquired and hereditary causes of venous thrombosis
Special Instructions
Informed consent is required for New York patients. If abnormal, aPTT will reflex immediately to aPTT Mixing Studies [117199] at an additional charge.
Specimen Requirements
Specimen
Plasma, whole blood, and serum
Volume
Three tubes as follows: 2 mL citrated plasma, 5 mL whole blood, and 2 mL serum
Container
Plasma: blue-top (sodium citrate) tube; whole blood: lavender-top (EDTA) tube or yellow-top (ACD) tube; serum: red-top tube or gel-barrier tube
Collection Instructions
Serum and plasma must be separated from cells within 45 minutes of venipuncture. Centrifuge plasma a second time before transferring to plastic transport tubes. Freeze within two hours and keep frozen until testing is performed. Send serum in a plastic transport tube. To avoid delays in turnaround time when requesting multiple tests on frozen samples, please submit separate frozen specimens for each test requested.
Storage Instructions
Maintain whole blood at room temperature. Freeze serum and plasma.
LOINC® Map
Order Code | Order Code Name | Order Loinc | Result Code | Result Code Name | UofM | Result LOINC |
---|---|---|---|---|---|---|
502073 | ThrombAssure(TM) Enhanced | 501701 | Homocysteine | umol/L | 13965-9 | |
502073 | ThrombAssure(TM) Enhanced | 500573 | Antithrombin Activity, Plasma | % | 27811-9 | |
502073 | ThrombAssure(TM) Enhanced | 500464 | Prt C Activity (Chromogenic) | % | 27818-4 | |
502073 | ThrombAssure(TM) Enhanced | 500618 | Protein S Antigen, Free | % | 27821-8 | |
502073 | ThrombAssure(TM) Enhanced | 500513 | APTT | sec | 14979-9 | |
502073 | ThrombAssure(TM) Enhanced | 500363 | APTT 1:1 NP | sec | 5946-9 | |
502073 | ThrombAssure(TM) Enhanced | 500364 | APTT 1:1 Saline | Sec | 43734-3 | |
502073 | ThrombAssure(TM) Enhanced | 501549 | DRVVT Screen Seconds | sec | 6303-2 | |
502073 | ThrombAssure(TM) Enhanced | 501548 | DRVVT Confirm Seconds | sec | 57838-5 | |
502073 | ThrombAssure(TM) Enhanced | 500585 | DRVVT Ratio | ratio | 50410-0 | |
502073 | ThrombAssure(TM) Enhanced | 500569 | Hexagonal Phospholipid Neutral | sec | 3282-1 | |
502073 | ThrombAssure(TM) Enhanced | 500575 | Anticardiolipin Ab, IgG | GPL | 3181-5 | |
502073 | ThrombAssure(TM) Enhanced | 500571 | Anticardiolipin Ab, IgM | MPL | 3182-3 | |
502073 | ThrombAssure(TM) Enhanced | 500581 | Anticardiolipin Ab, IgA | APL | 5076-5 | |
502073 | ThrombAssure(TM) Enhanced | 500589 | Beta-2 Glycoprotein I, IgG | SGU | 16135-6 | |
502073 | ThrombAssure(TM) Enhanced | 500593 | Beta-2 Glycoprotein I, IgM | SMU | 16136-4 | |
502073 | ThrombAssure(TM) Enhanced | 500591 | Beta-2 Glycoprotein I, IgA | SAU | 21108-6 | |
502073 | ThrombAssure(TM) Enhanced | 500587 | Factor V Leiden Result | 21667-1 | ||
502073 | ThrombAssure(TM) Enhanced | 500627 | Interpretation: | 51968-6 | ||
502073 | ThrombAssure(TM) Enhanced | 500628 | Methodology: | 49549-9 | ||
502073 | ThrombAssure(TM) Enhanced | 500629 | Comments: | 77202-0 | ||
502073 | ThrombAssure(TM) Enhanced | 500583 | Factor II Gene Mutation Result | 24476-4 | ||
502073 | ThrombAssure(TM) Enhanced | 500624 | Interpretation: | 51968-6 | ||
502073 | ThrombAssure(TM) Enhanced | 500625 | Methodology: | 49549-9 | ||
502073 | ThrombAssure(TM) Enhanced | 500626 | Comments: | 77202-0 | ||
502073 | ThrombAssure(TM) Enhanced | 502038 | LAC Interpretation | 77202-0 | ||
Order Code | 502073 | |||||
Order Code Name | ThrombAssure(TM) Enhanced | |||||
Order Loinc | ||||||
Result Code | 501701 | |||||
Result Code Name | Homocysteine | |||||
UofM | umol/L | |||||
Result LOINC | 13965-9 | |||||
Order Code | 502073 | |||||
Order Code Name | ThrombAssure(TM) Enhanced | |||||
Order Loinc | ||||||
Result Code | 500573 | |||||
Result Code Name | Antithrombin Activity, Plasma | |||||
UofM | % | |||||
Result LOINC | 27811-9 | |||||
Order Code | 502073 | |||||
Order Code Name | ThrombAssure(TM) Enhanced | |||||
Order Loinc | ||||||
Result Code | 500464 | |||||
Result Code Name | Prt C Activity (Chromogenic) | |||||
UofM | % | |||||
Result LOINC | 27818-4 | |||||
Order Code | 502073 | |||||
Order Code Name | ThrombAssure(TM) Enhanced | |||||
Order Loinc | ||||||
Result Code | 500618 | |||||
Result Code Name | Protein S Antigen, Free | |||||
UofM | % | |||||
Result LOINC | 27821-8 | |||||
Order Code | 502073 | |||||
Order Code Name | ThrombAssure(TM) Enhanced | |||||
Order Loinc | ||||||
Result Code | 500513 | |||||
Result Code Name | APTT | |||||
UofM | sec | |||||
Result LOINC | 14979-9 | |||||
Order Code | 502073 | |||||
Order Code Name | ThrombAssure(TM) Enhanced | |||||
Order Loinc | ||||||
Result Code | 500363 | |||||
Result Code Name | APTT 1:1 NP | |||||
UofM | sec | |||||
Result LOINC | 5946-9 | |||||
Order Code | 502073 | |||||
Order Code Name | ThrombAssure(TM) Enhanced | |||||
Order Loinc | ||||||
Result Code | 500364 | |||||
Result Code Name | APTT 1:1 Saline | |||||
UofM | Sec | |||||
Result LOINC | 43734-3 | |||||
Order Code | 502073 | |||||
Order Code Name | ThrombAssure(TM) Enhanced | |||||
Order Loinc | ||||||
Result Code | 501549 | |||||
Result Code Name | DRVVT Screen Seconds | |||||
UofM | sec | |||||
Result LOINC | 6303-2 | |||||
Order Code | 502073 | |||||
Order Code Name | ThrombAssure(TM) Enhanced | |||||
Order Loinc | ||||||
Result Code | 501548 | |||||
Result Code Name | DRVVT Confirm Seconds | |||||
UofM | sec | |||||
Result LOINC | 57838-5 | |||||
Order Code | 502073 | |||||
Order Code Name | ThrombAssure(TM) Enhanced | |||||
Order Loinc | ||||||
Result Code | 500585 | |||||
Result Code Name | DRVVT Ratio | |||||
UofM | ratio | |||||
Result LOINC | 50410-0 | |||||
Order Code | 502073 | |||||
Order Code Name | ThrombAssure(TM) Enhanced | |||||
Order Loinc | ||||||
Result Code | 500569 | |||||
Result Code Name | Hexagonal Phospholipid Neutral | |||||
UofM | sec | |||||
Result LOINC | 3282-1 | |||||
Order Code | 502073 | |||||
Order Code Name | ThrombAssure(TM) Enhanced | |||||
Order Loinc | ||||||
Result Code | 500575 | |||||
Result Code Name | Anticardiolipin Ab, IgG | |||||
UofM | GPL | |||||
Result LOINC | 3181-5 | |||||
Order Code | 502073 | |||||
Order Code Name | ThrombAssure(TM) Enhanced | |||||
Order Loinc | ||||||
Result Code | 500571 | |||||
Result Code Name | Anticardiolipin Ab, IgM | |||||
UofM | MPL | |||||
Result LOINC | 3182-3 | |||||
Order Code | 502073 | |||||
Order Code Name | ThrombAssure(TM) Enhanced | |||||
Order Loinc | ||||||
Result Code | 500581 | |||||
Result Code Name | Anticardiolipin Ab, IgA | |||||
UofM | APL | |||||
Result LOINC | 5076-5 | |||||
Order Code | 502073 | |||||
Order Code Name | ThrombAssure(TM) Enhanced | |||||
Order Loinc | ||||||
Result Code | 500589 | |||||
Result Code Name | Beta-2 Glycoprotein I, IgG | |||||
UofM | SGU | |||||
Result LOINC | 16135-6 | |||||
Order Code | 502073 | |||||
Order Code Name | ThrombAssure(TM) Enhanced | |||||
Order Loinc | ||||||
Result Code | 500593 | |||||
Result Code Name | Beta-2 Glycoprotein I, IgM | |||||
UofM | SMU | |||||
Result LOINC | 16136-4 | |||||
Order Code | 502073 | |||||
Order Code Name | ThrombAssure(TM) Enhanced | |||||
Order Loinc | ||||||
Result Code | 500591 | |||||
Result Code Name | Beta-2 Glycoprotein I, IgA | |||||
UofM | SAU | |||||
Result LOINC | 21108-6 | |||||
Order Code | 502073 | |||||
Order Code Name | ThrombAssure(TM) Enhanced | |||||
Order Loinc | ||||||
Result Code | 500587 | |||||
Result Code Name | Factor V Leiden Result | |||||
UofM | ||||||
Result LOINC | 21667-1 | |||||
Order Code | 502073 | |||||
Order Code Name | ThrombAssure(TM) Enhanced | |||||
Order Loinc | ||||||
Result Code | 500627 | |||||
Result Code Name | Interpretation: | |||||
UofM | ||||||
Result LOINC | 51968-6 | |||||
Order Code | 502073 | |||||
Order Code Name | ThrombAssure(TM) Enhanced | |||||
Order Loinc | ||||||
Result Code | 500628 | |||||
Result Code Name | Methodology: | |||||
UofM | ||||||
Result LOINC | 49549-9 | |||||
Order Code | 502073 | |||||
Order Code Name | ThrombAssure(TM) Enhanced | |||||
Order Loinc | ||||||
Result Code | 500629 | |||||
Result Code Name | Comments: | |||||
UofM | ||||||
Result LOINC | 77202-0 | |||||
Order Code | 502073 | |||||
Order Code Name | ThrombAssure(TM) Enhanced | |||||
Order Loinc | ||||||
Result Code | 500583 | |||||
Result Code Name | Factor II Gene Mutation Result | |||||
UofM | ||||||
Result LOINC | 24476-4 | |||||
Order Code | 502073 | |||||
Order Code Name | ThrombAssure(TM) Enhanced | |||||
Order Loinc | ||||||
Result Code | 500624 | |||||
Result Code Name | Interpretation: | |||||
UofM | ||||||
Result LOINC | 51968-6 | |||||
Order Code | 502073 | |||||
Order Code Name | ThrombAssure(TM) Enhanced | |||||
Order Loinc | ||||||
Result Code | 500625 | |||||
Result Code Name | Methodology: | |||||
UofM | ||||||
Result LOINC | 49549-9 | |||||
Order Code | 502073 | |||||
Order Code Name | ThrombAssure(TM) Enhanced | |||||
Order Loinc | ||||||
Result Code | 500626 | |||||
Result Code Name | Comments: | |||||
UofM | ||||||
Result LOINC | 77202-0 | |||||
Order Code | 502073 | |||||
Order Code Name | ThrombAssure(TM) Enhanced | |||||
Order Loinc | ||||||
Result Code | 502038 | |||||
Result Code Name | LAC Interpretation | |||||
UofM | ||||||
Result LOINC | 77202-0 |